Yantai Zhenghai Bio-Tech Co Ltd Net Asset Quality Index
Yantai Zhenghai Bio-Tech Co Ltd net asset quality index. Yantai Zhenghai Bio-Tech Co Ltd (300653) has a Net Asset Quality Index of 90.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.00 Billion minus total liabilities of CN¥98.66 Million yields net assets of CN¥904.23 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Yantai Zhenghai Bio-Tech Co Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Yantai Zhenghai Bio-Tech Co Ltd (2012–2025)
Net asset quality index of Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2025. This chart shows how Yantai Zhenghai Bio-Tech Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 90.2%, representing net assets of CN¥904.23 Million against total assets of CN¥1.00 Billion CNY. Check Yantai Zhenghai Bio-Tech Co Ltd (300653) strategic investment index to assess the company's strategic physical and investment asset allocation.
Yantai Zhenghai Bio-Tech Co Ltd Net Asset Quality Index by Year (2012–2025)
Yantai Zhenghai Bio-Tech Co Ltd net asset quality index by year from 2012 to 2025. The table below presents the year-by-year Net Asset Quality Index for Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Yantai Zhenghai Bio-Tech Co Ltd market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.3% | CN¥889.48 Million | CN¥984.62 Million | CN¥95.14 Million | ▼ -0.3 pp |
| 2024 | 90.7% | CN¥888.78 Million | CN¥980.11 Million | CN¥91.33 Million | ▲ +0.7 pp |
| 2023 | 90.0% | CN¥948.07 Million | CN¥1.05 Billion | CN¥105.76 Million | ▲ +2.3 pp |
| 2022 | 87.7% | CN¥865.11 Million | CN¥986.90 Million | CN¥121.80 Million | ▲ +3.1 pp |
| 2021 | 84.5% | CN¥785.27 Million | CN¥928.92 Million | CN¥143.65 Million | ▲ +4.3 pp |
| 2020 | 80.3% | CN¥646.72 Million | CN¥805.54 Million | CN¥158.82 Million | ▼ -1.4 pp |
| 2019 | 81.7% | CN¥588.38 Million | CN¥720.45 Million | CN¥132.06 Million | ▼ -8.9 pp |
| 2018 | 90.6% | CN¥529.00 Million | CN¥583.98 Million | CN¥54.99 Million | ▼ -0.4 pp |
| 2017 | 91.0% | CN¥483.18 Million | CN¥530.82 Million | CN¥47.63 Million | ▲ +3.0 pp |
| 2016 | 88.0% | CN¥228.16 Million | CN¥259.14 Million | CN¥30.98 Million | ▼ -1.5 pp |
| 2015 | 89.5% | CN¥179.40 Million | CN¥200.35 Million | CN¥20.95 Million | ▲ +12.2 pp |
| 2014 | 77.3% | CN¥63.62 Million | CN¥82.31 Million | CN¥18.69 Million | ▲ +39.6 pp |
| 2013 | 37.7% | CN¥29.34 Million | CN¥77.79 Million | CN¥48.46 Million | ▲ +44.7 pp |
| 2012 | -7.0% | CN¥-6.43 Million | CN¥91.78 Million | CN¥98.21 Million | — |